secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2021-09-15T23:59:59+00:00
Accession:  0001213900-21-048212
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma issues 1.76M shares to CEO to offset accrued compensation; grants option to director
--------------------------------------------------------------------------------

- Compensation Committee approved 1,760,000 shares to CEO Zhilin Li at $0.67/share to partially offset $1,666,706 in accrued unpaid cash compensation.
- Unpaid cash compensation reduced from $1,666,706 to $487,506 after share issuance.
- Director Gene Michael Bennett granted immediate-vest incentive stock option to purchase 65,000 shares at $1.47/share, expiring Sept 9, 2024.
- Options granted under 2010 Long-Term Incentive Plan; shares/options vest immediately with no restrictions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390021048212/0001213900-21-048212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390021048212/ea147480-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-048212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer